NervGen Pharma (NGENF) Short Interest Ratio & Short Volume $2.53 +0.28 (+12.44%) As of 05/2/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock NervGen Pharma Short Interest DataNervGen Pharma (NGENF) has a short interest of 316,500 shares, representing 0.51% of the float (the number of shares available for trading by the public). This marks a 10.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 60,936 shares to cover all short positions.Current Short Interest316,500 sharesPrevious Short Interest286,400 sharesChange Vs. Previous Month+10.51%Dollar Volume Sold Short$680,475.00Short Interest Ratio1.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares61,770,000 sharesShort Percent of Float0.51%Today's Trading Volume283,494 sharesAverage Trading Volume60,936 sharesToday's Volume Vs. Average465% Short Selling NervGen Pharma? Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNGENF Short Interest Over TimeNGENF Days to Cover Over TimeNGENF Percentage of Float Shorted Over Time NervGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025316,500 shares $680,475.00 +10.5%0.5%1.5 $2.15 3/31/2025286,400 shares $572,800.00 +3.7%0.5%2.5 $2.00 3/15/2025276,200 shares $524,780.00 +2.2%0.4%2.9 $1.90 2/28/2025270,300 shares $517,624.50 -2.8%0.4%2.5 $1.92 2/15/2025278,000 shares $581,020.00 +1.1%0.5%4.5 $2.09 1/31/2025275,100 shares $539,883.75 -19.4%N/A2.9 $1.96 1/15/2025341,400 shares $716,940.00 -6.7%N/A2.6 $2.10 12/31/2024366,000 shares $797,880.00 +37.2%N/A1.6 $2.18 12/15/2024266,800 shares $506,920.00 -0.9%N/A3 $1.90 11/30/2024269,200 shares $545,130.00 -4.2%N/A2.5 $2.03 Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024281,100 shares $410,406.00 +4.0%N/A1.6 $1.46 10/31/2024270,200 shares $470,148.00 -3.6%N/A2.6 $1.74 10/15/2024280,200 shares $504,360.00 +2.8%N/A3 $1.80 9/30/2024272,700 shares $518,130.00 +2.1%N/A4.3 $1.90 9/15/2024267,200 shares $502,336.00 -0.3%N/A2.7 $1.88 8/31/2024268,000 shares $557,440.00 -1.1%N/A4.8 $2.08 8/15/2024270,900 shares $574,037.10 -0.3%N/A2.9 $2.12 7/31/2024271,700 shares $562,419.00 -28.0%N/A4.6 $2.07 7/15/2024377,500 shares $856,925.00 +10.7%N/A1.7 $2.27 6/30/2024340,900 shares $674,982.00 -10.0%N/A2.1 $1.98 6/15/2024378,700 shares $640,003.00 +27.8%N/A1.5 $1.69 5/31/2024296,400 shares $423,852.00 +5.3%N/A1.5 $1.43 5/15/2024281,500 shares $433,510.00 +1.9%N/A3.7 $1.54 4/30/2024276,400 shares $420,128.00 +301.2%N/A2.9 $1.52 4/15/202468,900 shares $103,350.00 -83.5%N/A0.6 $1.50 3/31/2024416,300 shares $670,243.00 +67.8%N/A1.3 $1.61 3/15/2024248,100 shares $474,069.48 +151.4%N/A2.3 $1.91 2/29/202498,700 shares $251,685.00 +296.4%N/A0.9 $2.55 2/15/202424,900 shares $63,412.83 +38.3%N/A0.1 $2.55 1/15/202444,600 shares $88,085.00 -1.8%N/A0.3 $1.98 12/31/202345,400 shares $92,616.00 +1,791.7%N/A0.2 $2.04 12/15/20232,400 shares $2,955.60 +700.0%N/A0 $1.23 11/30/2023300 shares $393.00 -96.0%N/A0 $1.31 11/15/20237,400 shares $10,567.20 +13.9%N/A0.1 $1.43 10/31/20236,500 shares $8,710.00 +333.3%N/A0.1 $1.34 10/15/20231,500 shares $1,943.40 -81.9%N/A0 $1.30 9/30/20238,300 shares $11,715.45 +6.4%N/A0.2 $1.41 9/15/20237,800 shares $11,934.00 -57.1%N/A0.1 $1.53 8/31/202318,200 shares $27,614.86 +237.0%N/A0.2 $1.52 8/15/20235,400 shares $7,162.02 -79.6%N/A0.1 $1.33Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/31/202326,500 shares $34,185.00 +6.4%N/A1 $1.29 7/15/202324,900 shares $32,619.00 -2.7%N/A0.8 $1.31 6/30/202325,600 shares $31,744.00 -20.0%N/A0.4 $1.24 6/15/202332,000 shares $41,600.00 -32.9%N/A1.2 $1.30 5/31/202347,700 shares $62,010.00 +166.5%N/A1.1 $1.30 5/15/202317,900 shares $20,943.00 +96.7%N/A0.4 $1.17 4/30/20239,100 shares $10,556.00 -50.5%N/A0.1 $1.16 4/15/202318,400 shares $24,381.84 +318.2%N/A0.4 $1.33 3/31/20234,400 shares $5,425.20 +7.3%N/A0.1 $1.23 3/15/20234,100 shares $5,104.50 -33.9%N/A0.1 $1.25 2/28/20236,200 shares $8,556.00 +463.6%N/A0.1 $1.38 2/15/20231,100 shares $1,606.00 -38.9%N/A0 $1.46 1/31/20231,800 shares $2,907.00 +200.0%N/A0 $1.62 1/15/2023600 shares $864.00 -83.8%N/A0 $1.44 12/30/20223,700 shares $4,403.00 +516.7%N/A0.1 $1.19 12/15/2022600 shares $720.00 -81.8%N/A0 $1.20 11/30/20223,300 shares $4,686.00 -13.2%N/A0.1 $1.42 11/15/20223,800 shares $4,959.00 +111.1%N/A0.1 $1.31 10/31/20221,800 shares $2,358.00 -56.1%N/A0.1 $1.31 10/15/20224,100 shares $5,084.00 -73.6%N/A0.1 $1.24 9/30/202215,500 shares $20,770.00 +453.6%N/A0.2 $1.34 9/15/20222,800 shares $4,125.24 -42.9%N/A0.1 $1.47 8/31/20224,900 shares $7,399.00 No ChangeN/A0.1 $1.51 7/31/202210,500 shares $17,640.00 -34.4%N/A0.1 $1.68 7/15/202216,000 shares $24,160.00 -67.8%N/A0.1 $1.51 6/30/202249,700 shares $74,550.00 +100.4%N/A0.3 $1.50 6/15/202224,800 shares $35,960.00 +113.8%N/A0.2 $1.45 5/31/202211,600 shares $18,328.00 +4.5%N/A0.1 $1.58 5/15/202211,100 shares $18,648.00 +40.5%N/A0.1 $1.68 4/30/20227,900 shares $13,965.62 -69.3%N/A0 $1.77 4/15/202225,700 shares $45,440.17 +403.9%N/A0.2 $1.77 3/31/20225,100 shares $7,395.00 +183.3%N/A0 $1.45 3/15/20221,800 shares $3,384.00 -63.3%N/A0 $1.88 2/28/20224,900 shares $7,938.00 +444.4%N/A0.1 $1.62 2/15/2022900 shares $1,692.00 -87.0%N/A0 $1.88 1/31/20226,900 shares $12,661.50 +165.4%N/A0.1 $1.84 1/15/20222,600 shares $5,538.00 -78.5%N/A0.1 $2.13 12/31/202112,100 shares $25,773.00 +656.3%N/A0.2 $2.13 12/15/20211,600 shares $3,296.00 -89.7%N/A0 $2.06 11/30/202115,500 shares $35,650.00 +4.0%N/A0.1 $2.30 11/15/202114,900 shares $37,101.00 +129.2%N/A0 $2.49 10/29/20216,500 shares $15,177.50 +6,400.0%N/A0 $2.34 10/15/2021100 shares $189.00 -99.4%N/A0 $1.89 9/30/202115,800 shares $29,704.00 No ChangeN/A0.3 $1.88 8/31/20211,800 shares $2,970.00 -73.5%N/A0 $1.65 8/13/20216,800 shares $11,409.72 +65.9%N/A0.2 $1.68 7/30/20214,100 shares $5,781.00 +64.0%N/A0.1 $1.41 7/15/20212,500 shares $3,506.25 No ChangeN/A0 $1.40 6/30/20212,500 shares $3,147.25 -82.0%N/A0 $1.26 6/15/202113,900 shares $17,242.95 +195.7%N/A0.1 $1.24Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 5/28/20214,800 shares $5,232.00 -11.1%N/A0.3 $1.09 5/14/20215,400 shares $6,345.00 +42.1%N/A0.2 $1.18 4/30/20213,800 shares $5,396.00 +65.2%N/A0.1 $1.42 4/15/20212,300 shares $3,128.00 -79.1%N/A0.1 $1.36 3/31/202111,000 shares $14,696.00 +746.2%N/A0.3 $1.34 3/15/20211,300 shares $2,014.35 -50.0%N/A0 $1.55 2/26/20212,600 shares $4,576.00 -71.7%N/A0.1 $1.76 2/12/20219,200 shares $17,756.00 +70.4%N/A0.3 $1.93 1/29/20215,400 shares $10,553.22 +2,600.0%N/A0.1 $1.95 12/31/20202,100 shares $3,559.50 No ChangeN/A0.1 $1.70 11/30/2020900 shares $1,224.00 -52.6%N/A0 $1.36 11/15/20201,900 shares $2,717.00 -5.0%N/A0.1 $1.43 10/30/20202,000 shares $2,480.00 -59.2%N/A0.1 $1.24 10/15/20204,900 shares $5,279.75 +1,125.0%N/A0.1 $1.08 9/30/20201,700 shares $1,705.61 -95.3%N/A0.1 $1.00 9/15/202035,800 shares $29,714.00 +118.3%N/A0.9 $0.83 8/31/202016,400 shares $10,610.80 +720.0%N/A1 $0.65 8/14/20202,000 shares $1,260.00 +81.8%N/A0 $0.63 NGENF Short Interest - Frequently Asked Questions What is NervGen Pharma's current short interest? Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 316,500 shares of NGENF short. 0.51% of NervGen Pharma's shares are currently sold short. Learn More on NervGen Pharma's current short interest. What is a good short interest ratio for NervGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGENF shares currently have a short interest ratio of 2.0. Learn More on NervGen Pharma's short interest ratio. What is a good short interest percentage for NervGen Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.51% of NervGen Pharma's floating shares are currently sold short. Is NervGen Pharma's short interest increasing or decreasing? NervGen Pharma saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 316,500 shares, an increase of 10.5% from the previous total of 286,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NervGen Pharma's short interest compare to its competitors? 0.51% of NervGen Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NervGen Pharma: NovaBay Pharmaceuticals, Inc. (3.31%), Talkspace, Inc. (3.20%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short NervGen Pharma stock? Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NGENF shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NervGen Pharma? A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further. How often is NervGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies NovaBay Pharmaceuticals Short Interest Data 3SBio Short Interest Data Agentix Short Interest Data Algernon Pharmaceuticals Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data AXIM Biotechnologies Short Interest Data Talkspace Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NGENF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NervGen Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NervGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NGENF Stock Free NGENF Stock Alerts